Harbour Investments, Inc. Shockwave Medical, Inc. Transaction History

Harbour Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 22, 2024	SELL	$191.17 - $325.63 $129,995 - $221,428	-680 Reduced 28.27%	1,725 $561,000
Q4 2023 Feb 16, 2024	BUY	$160.99 - $215.69 $50,389 - $67,510	313 Added 14.96%	2,405 $458,000
Q3 2023 Nov 15, 2023	BUY	$194.33 - $283.97 $205,795 - $300,724	1,059 Added 102.52%	2,092 $416,000
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $59,554 - $80,815	-267 Reduced 20.54%	1,033 $294,000
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $7,191 - $8,934	41 Added 3.26%	1,300 $281,000
Q4 2022 Feb 15, 2023	SELL	$204.38 - $296.82 $42,102 - $61,144	-206 Reduced 14.06%	1,259 $258,000
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $45,436 - $84,076	392 Added 36.53%	1,465 $280,000
Q4 2021 Feb 16, 2022	BUY	$165.13 - $241.83 $8,586 - $12,575	52 Added 5.09%	1,073 $191,000
Q2 2021 Aug 16, 2021	BUY	$131.45 - $201.49 $1,708 - $2,619	13 Added 1.29%	1,021 $194,000
Q1 2021 Aug 17, 2021	BUY	$92.73 - $142.05 $90,226 - $138,214	973 Added 2780.0%	1,008 $131,000
Q1 2021 May 12, 2021	BUY	$92.73 - $142.05 $3,245 - $4,971	35 New	35 $5,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.